Table 1.
Clinical features | Lesion locations (lowest layer) | P | |
---|---|---|---|
≤ The 3rd level (183) BAD | > The 3rd level (129) SVD | ||
Age, years, mean ±SD | 61.7±12.2 | 64.7±11.2 | 0.031 |
Male, no. (%) | 131 (71.6%) | 84 (65.1%) | 0.264 |
Hypertension, no. (%) | 97 (53%) | 85 (65.9%) | 0.027 |
DM, no. (%) | 51 (27.9%) | 44 (34.1%) | 0.262 |
Hyperlipidemia, no. (%) | 25 (13.7%) | 25 (19.4%) | 0.21 |
History of CAD, no. (%) | 19 (10.4%) | 16 (12.4%) | 0.589 |
History of stroke, no. (%) | 49 (26.8%) | 39 (30.2%) | 0.525 |
Smoking, no. (%) | 106 (57.9%) | 54 (41.9%) | 0.006 |
NIHSS, median (IQR) | 4 (2–5) | 3 (1–5) | 0.201 |
Length (DWI), mean ±SD | 12.5±5.0 | 11.1±4.6 | 0.616 |
Height (FLAIR), mean ±SD | 14.1±6.7 | 10.7±5.3 | 0.000 |
PVH (Fazekas) ≥2, no. (%) | 90 (49.2%) | 89 (69%) | 0.001 |
DWMH (Fazekas) ≥2, no. (%) | 51 (27.9%) | 70 (54.3%) | 0.000 |